This Project Grant award from the National Science Foundation's (NSF) Engineering program (CFDA 47.041) provides $463,746 to the University of Puerto Rico Medical Sciences Campus (UPR-MSC) to study an innovative continuous crystallizer concept. The objective is to develop robust, scalable, and miniaturized equipment for pharmaceutical manufacturing that can improve resilience to supply chain disruptions and better meet fluctuating market needs. The research seeks to advance continuous crystallization, a key unit operation in pharmaceutical production. Specifically, the project aims to create miniaturized crystallizers under 100 mL to accommodate smaller production volumes of potent and precious pharmaceuticals, while also reducing consumption during early research and development. This effort involves partnerships between UPR-MSC, the Massachusetts Institute of Technology, and an industrial collaborator. The award period runs from September 1, 2023 to August 31, 2026.
Generated 6/18/24, 6:12 AM